Financial results - VIVAX PHARMACEUTICALS ROUMANIA S.R.L.

Financial Summary - Vivax Pharmaceuticals Roumania S.r.l.
Unique identification code: 40712326
Registration number: J2019002669403
Nace: 4646
Sales - Ron
-
Net Profit - Ron
-8.927
Employees
Open Account
Company Vivax Pharmaceuticals Roumania S.r.l. with Fiscal Code 40712326 recorded a turnover of 2024 of - , with a net profit of -8.927 and having an average number of employees of - . The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Vivax Pharmaceuticals Roumania S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 4.606 15.862 572.479 106.362 6.833 0
Total Income - EUR - - - - 4.606 15.862 572.479 106.512 6.833 2
Total Expenses - EUR - - - - 26.735 14.468 437.770 144.838 13.551 8.929
Gross Profit/Loss - EUR - - - - -22.130 1.394 134.709 -38.326 -6.718 -8.927
Net Profit/Loss - EUR - - - - -22.176 591 128.721 -39.391 -6.718 -8.927
Employees - - - - 2 1 1 1 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Vivax Pharmaceuticals Roumania S.r.l.

Rating financiar

Financial Rating -
VIVAX PHARMACEUTICALS ROUMANIA...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Vivax Pharmaceuticals Roumania...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Vivax Pharmaceuticals Roumania...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Vivax Pharmaceuticals Roumania...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Vivax Pharmaceuticals Roumania S.r.l. - CUI 40712326

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 416 409 3.077 2.724 2.355 1.983
Current Assets - - - - 3.833 9.447 144.595 20.443 13.779 7.954
Inventories - - - - 0 2.855 2.655 3.031 492 489
Receivables - - - - 1.445 4.752 113.469 12.683 8.443 4.884
Cash - - - - 2.388 1.840 28.471 4.730 4.844 2.581
Shareholders Funds - - - - -22.134 -21.124 108.066 -11.761 -18.443 -27.267
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 26.383 30.980 39.606 34.928 34.577 37.204
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 7.954 euro in 2024 which includes Inventories of 489 euro, Receivables of 4.884 euro and cash availability of 2.581 euro.
The company's Equity was valued at -27.267 euro, while total Liabilities amounted to 37.204 euro. Equity decreased by -8.927 euro, from -18.443 euro in 2023, to -27.267 in 2024.

Risk Reports Prices

Reviews - Vivax Pharmaceuticals Roumania S.r.l.

Comments - Vivax Pharmaceuticals Roumania S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.